소아에서 시행한 치료적 혈장교환술 9례의 임상적 고찰
An Experience of Therapeutic Plasma Exchange in 9 Pediatric Patients
0
조회
0
다운로드
2
인용
0
참고문헌
초록
목 적:본 연구에서는 소아의 다양한 질환에서 시행한 치료적 혈장 교환술 9례의 치료 경과를 분석하고자 하였다. 방법:원심 분리 기기를 이용한 COBE Spectra 기기를 이용하여 치료적 혈장 교환술을 시행하였으며 시행한 증례별로 원인 질환, 시행 횟수, 시행 방법, 치료 경과, 예후 등을 병록 기록지를 통하여 후향적으로 분석하였다. 결 과:대상 환아 9명의 연령 분포는 2세에서 16세로 평균 연령은 9.8세였으며 성비는 남아 5명, 여아 4명이었다. 치료적 혈장 교환술을 시행하게된 원인 질환은 용혈성 요독 증후군 2례, 루프스 신염 1례, 급속 진행성 신염 2례, 국소성 분절성 사구체 경화증 1례, 폐출혈로 발현한 전신성 혈관염 1례, 폐출혈을 동반한 원인 미상의 급성 신부전 1례, 신이식후 급성 거부 반응 1례였다. 혈장 교환 시행 횟수는 3회에서 13회로 평균 6.9±3.0회를 시행하였으며 용혈성 요독 증후군, 루프스 신염, 폐출혈로 발현한 ANCA 양성 전신성 혈관염, 원인 미상의 폐출혈 동반 신부전에서는 호전을 보였으며 급속 진행성 신염과 치료 저항성 국소성 분절성 사구체 경화증, 신이식후 급성 거부 반응에는 효과가 없었다. 시행 전후에 가장 흔한 부작용은 저 칼슘혈증이었으나 심각한 증상을 동반한 경우는 드물었으며 그 밖의 부작용도 경미하여 비교적 안전하게 치료적 혈장 교환술을 시행할 수 있었다. 결 론:본 연구에서는 대상 환아가 적은 제한점이 있어 치료 효과를 일반화하기 어려우나 향후 소아의 다양한 질환에서 혈장 교환술이 치료 방법으로 선택되어질 수 있을 것으로 보인다,
Abstract
Purpose:The purpose of this study was to analyze the therapeutic effect of plasmapheresis in various pediatric diseases. Methods:Therapeutic plasmapheresis was performed by COBE Spectra centrifugation. Nine cases were included in this study. The number and method of plasmapheresis, together with the progress and prognosis of each case were retrospectively reviewed. Results:The patients' ages ranged from 26 months to 16 years of age, and the mean age was 9.9 years. There were 5 males and 4 females. The underlying diseases requiring plasmapheresis included 2 cases of hemolytic uremic syndrome(HUS), 1 case of lupus nephritis, 2 cases of rapidly progressive glomerulonephritis(RPGN), 1 case of focal segmental glomerulosclerosis(FSGS), 1 case of systemic vasculitis after pulmonary hemorrhage, 1 case of acute renal failure associated with pulmonary hemorrhage, and 1 case of acute rejection after renal transplantation. The average number of plasmapheresis performed was 6.2 times with a range of 3 to 13 times. The patients with HUS, lupus nephritis, ANCA positive systemic vasculitis induced by pulmonary hemorrhage and ARF-associated pulmonary hemorrhage showed a good response to therapeutic plasmapheresis, but the patients with RPGN, refractory FSGS, and acute rejection after renal transplantation were not responsive to treatment. The most common side effect was hypocalcemia which was rarely symptomatic. Vital signs were not compromised. Conclusion:Although it is presumptuous to generalize the therapeutic effects of plasmapheresis in different diseases due to the small number of study subjects, this study shows that plasmapheresis may be an effective therapeutic modality in various pediatrics diseases and should be considered as a therapeutic option.
참고문헌 (18)
- American Society for Apheresis, "Organizational guidelines for therapeutic apheresis facilities", 11, pp.42~5 (1996)
- Um TH, "Experience of therapeutic plasma exchange in Seoul National University Hospital", 4, pp.199~205 (1993)
- Kaplan AA, "Toward the rational prescription of therapeutic plasma exchange:the kinetics of immunoglobulin removal", 5, pp.227~9 (1992)
- Song EY, "Current status of therapeutic plasma exchange in Korea", 8, pp.97~101 (2004)
- Malchesky PS, "Apheresis technologies and clinical applications:the 2000 international Apheresis registry", 5, pp.193~206 (2001)
- Bell WR, "Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Clinical experience in 108 patients", pp.398~403
- Hwang WYK, "Therapeutic plasmapheresis for the treatment of the thrombotic thrombocutopenic purpura-haemolytic uraemic syndromes", 45, pp.219~23 (2004)
- Kim HY, "Clinical feature and response to plasma exchange in adult patients with diarrhea-associated hemolytic uremic syndrome", 17, pp.887~95 (1998)
- Madore Francois, "Plasmapheresis technical aspects and indications", 18, pp.375~92 (2002)
- Lewis EJ, "A controlled trial of plasmapheresis therapy in severe lupus nephritis", 326, pp.1373~9 (1992)
- Min JH, "A case of successful treatment of pulmonary alveolar hemorrhage with plasmapheresis in child with systemic lupus erythematosus", 41, pp.974~8 (1998)
- Zauner I, "Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis", 39, pp.28~35 (2002)
- Cho HY, "A clinicopathological study of rapidly progressive glomerulonephritis in children", 8, pp.176~85 (2004)
- Uhm JH, "Analysis of childhood rapidly progressive glomerulonephritis", 5, pp.78~86 (2001)
- Vecsei AKW, "Plasmapheresis-induced remission in otherwise therapy-resistant FSGS", 16, pp.898~900 (2001)
- Mitwallli AH, "Adding plasmapheresis to corticosteroids and alkylating agents:does it benefit patients with focal segmental glomerulosclerosis", 13, pp.1524~8 (1998)
- Kim L, "Therapeutic effect of plasmapheresis in relapsed focal segmental glmerulosclerosis after steroid pulse therapy", 7, pp.1~8 (2003)
- Klemmer PJ, "Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis", 42, pp.1149~53 (2003)